Literature DB >> 5331182

Treatment of refractory obesity with fenfluramine.

J F Munro, D A Seaton, L J Duncan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5331182      PMCID: PMC1943487          DOI: 10.1136/bmj.2.5514.624

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  [PHARMACOLOGICAL COMPARISON OF 7 ANOREXIGENIC DRUGS].

Authors:  J C LEDOUAREC; H SCHMITT
Journal:  Therapie       Date:  1964 Jul-Aug       Impact factor: 2.070

2.  CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY.

Authors:  D A SEATON; K ROSE; L J DUNCAN
Journal:  Practitioner       Date:  1964-11

3.  A PRELIMINARY TRIAL OF FENFLURAMINE IN GENERAL PRACTICE.

Authors:  E H DUNCAN; C A HYDE; N A REGAN; B SWEETMAN
Journal:  Br J Clin Pract       Date:  1965-08

4.  Diethyl-propion in the treatment of "refractory" obesity.

Authors:  D A SEATON; L J DUNCAN; K ROSE; A M SCOTT
Journal:  Br Med J       Date:  1961-04-08

5.  Phenmetrazine hydrochloride and methylcellulose in the treatment of "refractory" obesity.

Authors:  L J DUNCAN; K ROSE; A P MEIKLEJOHN
Journal:  Lancet       Date:  1960-06-11       Impact factor: 79.321

6.  A clinical trial of fenfluramine.

Authors:  J B Traherne
Journal:  Practitioner       Date:  1965-11
  6 in total
  25 in total

1.  The usefulness of fenfluramine in treating simple obesity.

Authors:  J P Sedgwick
Journal:  Can Fam Physician       Date:  1972-02       Impact factor: 3.275

2.  Comparison of continuous and intermittent anorectic therapy in obesity.

Authors:  J F Munro; A C MacCuish; E M Wilson; L J Duncan
Journal:  Br Med J       Date:  1968-02-10

3.  Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.

Authors:  W Buczko; G De Gaetano; S Garattini
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

4.  Peripheral effects of fenfluramine.

Authors:  G E Mitchell; D R Mottram
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

Review 5.  The management of obesity.

Authors:  J M Court
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Treatment of obesity with fenfluramine.

Authors:  I Persson; U Andersen; T Deckert
Journal:  Eur J Clin Pharmacol       Date:  1973-08       Impact factor: 2.953

Review 7.  Obesity.

Authors:  J Anderson
Journal:  Br Med J       Date:  1972-02-26

8.  The effect of a low-calorie diet with and without fenfluramine, and fenfluramine alone on the glucose tolerance and insulin secretion of overweight non-diabetics.

Authors:  J R Dykes
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

9.  Drugs and sleep.

Authors:  I Oswald
Journal:  Br Med J       Date:  1968-06-01

Review 10.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.